MJBizDaily
After Trulieve, which cannabis MSO will be next to uplist?
Latest Posts
Why the industry needs to defend federal marijuana rescheduling
"If you have a DEA license or are in a state-legal market, from a compliance perspective, that will be treated differently at an institution,” Bronstein said. “It will be treated…
News June 18
Federal cannabis rescheduling may not apply in Washington, regulator warns
Since cannabis operators in Washington are licensed under a single-tier system, federal medical cannabis rescheduling may not be much help.
News June 17
Illinois folds hemp THC into regulated cannabis system, but drinks unclear
Gov. JB Pritzker had threatened to ban intoxicating hemp products entirely if lawmakers failed to establish regulations for the products.
News June 17
The New Genetics Race: Why Cannabis Seed Brands Are Becoming the Next Big Differentiator
As cannabis shoppers become more educated, seed brands are no longer just selling genetics — they are shaping loyalty, discovery, and the next wave of premium cultivation culture.
June 9
Michigan’s top cannabis regulator elected president of CANNRA
Regulators from Virginia, Illinois, Hawaii, Connecticut, Missouri and Iowa also will serve on CANNRA’s 2026-27 board.
News June 16
Virginia adult-use cannabis sales to begin July 2027 under new deal
License caps and tax rates both set in compromise that will see sales begin July 1, 2027.
News June 16
Canopy Growth reports big jump in medical cannabis revenue
Canopy’s medical cannabis net revenue in the fourth quarter was $25.3 million. Its international revenue was $8.6 million.
News June 15
Texas court reinstates hemp rules, enforcement still unclear
The decision does not settle the broader lawsuit, but it removes a lower-court block that paused enforcement of portions of the regulations.
News June 12
Trulieve is first US cannabis company to trade on NYSE
CEO Kim Rivers called the listing a turning point for the cannabis sector. Analysts predict the company will break even in the next year.
News June 11
Missouri cannabis sales hit record $135.1 million in May
The average price of cannabis items sold dropped from $28.79 in May 2025 to $26.61 for the same month this year.
News June 10
Latest Sponsored
